CSR

Three major pharmas have shared end-of-year environmental, social and governance announcements over the past weeks.

Merck invested a new round of $150 million in essential maternal and reproductive health services funding for 25 million women by 2025 through its Merck for Mothers program.

Meanwhile, Takeda launched a new U.S. corporate social responsibility program with a first-year commitment of $20 million for “health equity, climate resiliency, K-8 math literacy and food…

As world leaders descended on the COP26 climate change conference in Glasgow this week, several pharma companies promoted their own ESG pledges.

First, Moderna on Monday outlined a commitment to achieve net-zero carbon emissions globally by 2030. The announcement touted a plan to use renewable or offset energy in all U.S. facilities starting this year and to implement sustainable construction for new plants in Africa and Canada. CEO Stéphane Bancel said in the press release that…

Teva announced Wednesday a $4 billion “sustainability-linked financing framework” that the company will use to refinance its debt while incentivizing its efforts to increase access to medicines in LMICs by 150%.

The Access to Medicine Foundation has independently validated the Tel Aviv-based company’s framework, which also includes a goal to reduce Scope 1 and 2 greenhouse gas emissions by 25% by 2025, the press release said.

Novartis and Sanofi have also issued bonds with rates…

Three pharmas published environmental, social and governance commitments this week.

First, BD released its 2021 Together We Advance strategy, promising to achieve carbon neutrality across direct operations by 2040, to work with supply chain partners on labor and environmental practices, and to improve ethnic and gender diversity at its management and executive levels by 1% year over year, among other measures.

Next up, GSK’s HIV subsidiary ViiV released a report conducted by…

Mentions:

Touting progress toward its November 2020 pledge to have a net-zero impact on climate and “net positive impact on nature” by 2030, GSK announced Monday a $68 million investment in renewable energy and carbon reduction at manufacturing sites, including facilities in Scotland and New York.

The investment will also support a new R&D program to reduce greenhouse gas emissions caused by the propellant in GSK’s medicine inhalers, which account for 45% of the company’s carbon emissions,…

Mentions:

Takeda announced Wednesday four new partnerships and nearly $38 million in investments for its annual Global Corporate Social Responsibility (CSR) Program, which makes “long-term commitments to strengthen health systems and improve access to healthcare” in developing and emerging countries.

The new investments include $8.7 million to IntraHealth International for healthcare access, over $8.1 million to Jhpiego’s iWIN project for maternal and child health, $9.1 million to Pathfinder…

Mentions:

Gilead announced a “more than $200 million endowment” to its eponymous foundation on Tuesday, outdoing the value of similar commitments announced in July by rivals Moderna and Novartis.

The funds will support the newly launched Creating Possible Fund—focused on “health justice”—as well as Gilead’s donation matching program for employees and other initiatives, according to a company press release. Gilead also said it provided $409 million in cash contributions in 2020 towards co-pay…

Moderna announced last week its launch of a foundation to promote “public health, healthcare and educational opportunities,” with an initial endowment of $50 million. The Moderna Charitable Foundation is the first public social good commitment for the maker of the blockbuster Covid-19 vaccine.

Meanwhile, Novartis last week announced a 10-year collaboration with multiple U.S.-based historically Black colleges and universities (HBCUs) and HCBU medical schools to co-create programs that…

Mentions:

Sanofi CEO Paul Hudson announced on Tuesday the creation of a nonprofit unit, Sanofi Global Health, which will provide 40 lower-income countries with access to 30 of the company’s “most essential medicines,” including cardiovascular, diabetes, tuberculosis, malaria and cancer treatments.

An accompanying press release said Sanofi Global Health will be the cornerstone of the Paris-based company’s corporate social responsibility strategy for “access to medicines, support for vulnerable…

Merck announced Tuesday the fifth round of global grants in its Merck for Mothers program, which funds organizations working to increase health equity in maternity care and support, according to its press release.

New grantees include a UNICEF program in Argentina focused on adolescents from indigenous communities and a Save the Children-backed project to support pregnant teenagers and young mothers in rural Moldova.

While describing the 10-year-old Merck for Mothers as a “$500…